Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Restrictive Cardiomyopathy

What is Restrictive Cardiomyopathy?

The heart is the organ that pumps blood to the body. Structurally, it is made up of four chambers: the right atrium, the right ventricle, the left atrium, and the left ventricle. The left atrium receives oxygenated blood from the lungs, passes it on to the left ventricle which then contracts to eject blood into blood vessels to supply oxygen and nutrients to the rest of the body and to remove wastes. As blood circulates, oxygen is taken up by different organs, making it deoxygenated. Deoxygenated blood enters the right atrium, is passed on to the right ventricle, and eventually is pumped into the lungs to become oxygenated again and return to the left atrium. Therefore, systemic and pulmonary circulation are terms that are used to describe these two circuits. The pulmonary circulation takes deoxygenated blood to the lungs and brings oxygenated blood back to the heart. The systemic circulation delivers oxygenated blood to the rest of the body and brings deoxygenated blood back to the heart. These two circuits are connected in series such that the blood that returns from one circuit enters the other and vice versa. 

 

The heart muscle cells or cardiomyocytes are crucial to this process as it is their contraction that builds the force required to eject blood out of the heart, and their relaxation and expansion allow blood to enter and fill the heart chambers. This contraction relies on an electrical conduction system within the heart muscle itself. 

 

Cardiomyopathy is a disease of the heart that hinders the ability of the heart to pump blood. There are different kinds of cardiomyopathy including restrictive cardiomyopathy (RCM). In each type, stiffening of the heart muscle, especially in the ventricles, impairs the expansion of the chambers. As a result, the heart cannot fully fill with blood, and subsequently, even though the contractile function of the heart is unimpaired, there is less blood available to be pumped into circulation. Since the systemic and pulmonary circulations are connected, cardiomyopathies affect both the heart and eventually the lungs. This leads to heart-related symptoms and complications such as irregular heart rhythms and heart failure as well as respiratory symptoms such as shortness of breath and coughing. Restrictive cardiomyopathy can be primary, which may be due to an unknown cause (idiopathic) or inherited, or it can be secondary to other conditions.

 

Synonyms

  • Restrictive Cardiomyopathy

The heart is the organ that pumps blood to the body. Structurally, it is made up of four chambers: the right atrium, the right ventricle, the left atrium, and the left ventricle. The left atrium receives oxygenated blood from the lungs, passes it on to the left ventricle which then contracts to eject blood into blood vessels to supply oxygen and nutrients to the rest of the body and to remove wastes. As blood circulates, oxygen is taken up by different organs, making it deoxygenated. Deoxygenated blood enters the right atrium, is passed on to the right ventricle, and eventually is pumped into the lungs to become oxygenated again and return to the left atrium. Therefore, systemic and pulmonary circulation are terms that are used to describe these two circuits. The pulmonary circulation takes deoxygenated blood to the lungs and brings oxygenated blood back to the heart. The systemic circulation delivers oxygenated blood to the rest of the body and brings deoxygenated blood back to the heart. These two circuits are connected in series such that the blood that returns from one circuit enters the other and vice versa. 

 

The heart muscle cells or cardiomyocytes are crucial to this process as it is their contraction that builds the force required to eject blood out of the heart, and their relaxation and expansion allow blood to enter and fill the heart chambers. This contraction relies on an electrical conduction system within the heart muscle itself. 

 

Cardiomyopathy is a disease of the heart that hinders the ability of the heart to pump blood. There are different kinds of cardiomyopathy including restrictive cardiomyopathy (RCM). In each type, stiffening of the heart muscle, especially in the ventricles, impairs the expansion of the chambers. As a result, the heart cannot fully fill with blood, and subsequently, even though the contractile function of the heart is unimpaired, there is less blood available to be pumped into circulation. Since the systemic and pulmonary circulations are connected, cardiomyopathies affect both the heart and eventually the lungs. This leads to heart-related symptoms and complications such as irregular heart rhythms and heart failure as well as respiratory symptoms such as shortness of breath and coughing. Restrictive cardiomyopathy can be primary, which may be due to an unknown cause (idiopathic) or inherited, or it can be secondary to other conditions.

Acknowledgement of Restrictive Cardiomyopathy has not been added yet.

The exact prevalence of RCM in the general population remains unknown. About 5% of all cardiomyopathy cases are RCM which is believed to be the least common type of cardiomyopathy. Primary RCM is less common than secondary RMC. Different causes of RCM have varying frequencies in different age groups. 

 

Most adult cases are secondary to another condition called amyloidosis. In amyloidosis, an abnormal protein called amyloid accumulates in different organs and interferes with their function. Amyloidosis affects men and women equally

 

In children, the most common cause is exposure to radiation or certain chemotherapy agents such as anthracyclines. In infants, RCM may occur secondary to certain metabolic syndromes such as Gaucher’s disease in which the build-up of certain fats reaches a harmful level.

 

Name Abbreviation
Restrictive Cardiomyopathy RCM

The causes of RCM can be classified into primary or secondary.

Primary RCM

More than half of primary RCM cases run in families, suggesting that it is inherited. Several genes have been associated with primary RCM. These include mutations in troponin T (TNNT2 gene), troponin I (TNNI3), α-actin (ACTC), and β-myosin heavy chain (MYH7). All these genes encode proteins that make up the functional units of muscle cells, known as sarcomeres. Mutations in genes are mostly inherited in an autosomal dominant fashion, meaning that one defective copy of the gene is enough for disease presentation. The cause of primary RCM in the other half is unknown (idiopathic). 

 

Secondary RCM

Secondary RCM occurs subsequently to another condition that affects the heart. Secondary RCM may occur as a result of infiltrative cardiac conditions which are characterized by the abnormal deposition of substances such as protein or fat within the heart muscle that stiffen the heart. For example, AL amyloidosis (immunoglobulin light chain amyloidosis) occurs when certain immune cells produce an abnormal protein that cannot be degraded by the body, leading to its harmful accumulation in different tissues including the heart muscle. The exact cause of AL amyloidosis is unknown.

 

In addition to heart infiltrative diseases, certain storage diseases can also cause RCM. Storage diseases are conditions that lead to the abnormal buildup of certain molecules within the cells. Most storage diseases are inherited as either autosomal recessive conditions or less commonly, in an X-linked manner. Autosomal recessive conditions only present if the individual has inherited 2 defective copies of the associated gene, one from each parent. The gene associated with an X-linked condition is located on the X chromosome, one of the two sex chromosomes in human cells. X-linked conditions primarily affect men. Hemochromatosis or iron storage disease is one of the common causes of secondary RCM. It is caused by a mutation in the HFE gene which encodes the HFE protein. HFE protein regulates the uptake of iron from the bloodstream into the cell. 

 

The last category of secondary causes of RCM is endomyocardial, which are conditions that affect the innermost layer of the heart that lines the insides of the heart chambers. For example, endomyocardial fibrosis can lead to scarring and the subsequent thickening of the inner layer of the heart. Although the exact cause of endomyocardial RCM is unknown, immune system dysfunction, genetic factors, infections, and environmental exposures may be implicated. 

 

Regardless of the underlying cause, RCM occurs when the heart muscle becomes too stiff and cannot properly expand and fill with blood when the heart is relaxing. Subsequently, when the heart contracts, there is less blood inside the heart to be ejected to the rest of the body. This means body organs receive less oxygen and nutrients and over time this may cause heart failure, a condition in which the heart cannot pump enough blood to meet the demands of the body. Over time, due to the impaired ability of the heart to expand, the blood returning to the heart cannot fully enter it. Therefore, pressure builds up until eventually there is high blood pressure in the pulmonary circuit in the lungs which causes the accumulation of fluids in the lungs. Additionally, the changes to the heart muscle may damage the electrical conduction system in the heart, leading to irregularities in the heartbeat (arrhythmias).

RCM tends to be a progressive condition that worsens over time. Initially, affected individuals may not experience any symptoms. Some symptoms that may develop with RCM include shortness of breath that gets worse with exercise. This is because during exercise, the body needs more oxygen and the heart’s impaired ability to pump blood becomes more pronounced due to the larger oxygen supply-demand imbalance. Affected individuals may also shortness of breath when lying down, fatigue, weakness, lightheadedness, fainting episodes, swelling in the legs and feet, coughing, chest pain or pressure, and abnormal heart rhythms that may be sensed as heart palpitations are heart racing. Due to the progressive nature of this condition, individuals may have very mild symptoms at first that worsen over time.

Additionally, depending on the underlying cause, other associated symptoms may be present. For example, if RCM is secondary to amyloidosis, affected individuals may experience numbness, tingling, or pain in their hands due to carpal tunnel, a condition associated with amyloidosis that causes the compression of the nerve that innervates the hands. Hemochromatosis can present with bronzing of the skin and joint pain. 

RCM may be suspected based on the presence of symptoms, the diagnosis of other conditions that are associated with RCM, family history, and physical examination. During the physical examination, the physician may listen to the heart. Certain abnormal heart sounds can point to certain conditions or abnormalities. The physician may also listen to the individual’s lungs to assess whether there is any fluid accumulation. Symptoms of conditions underlying secondary RCM may also become apparent during physical examination. If symptoms and physical exam findings point to a heart abnormality, a number of tests are needed to narrow down and confirm the diagnosis.  

An electrocardiography (ECG) may be performed to diagnose RCM. During an ECG, a number of small sensors are attached to the individual for a few minutes to record the electrical activity of the heart. Abnormalities in an ECG can point to or support certain diagnoses. A chest X-ray may also be performed to assess the size of the heart. However, both these tests are non-specific and cannot diagnose RCM. Echocardiography is an imaging test that utilizes sound waves to visualize the heart in real-time and can provide more detailed information about the function and anatomy of the heart muscle. In certain cases, an endomyocardial biopsy is required to confirm the diagnosis. This is an invasive procedure that allows for direct sampling of the heart tissue that can be analyzed. This procedure is performed by passing a small cutting device attached to a long, thin sheath through a blood vessel in the body, most commonly the internal jugular vein (a blood vessel in the neck) into the heart.

 

Currently, there are no cures for RCM. Management targets the underlying condition if identified, heart failure symptoms, and potential complications. For example, if RC is secondary to hemochromatosis, iron chelating medications may be used. These are agents that circulate in the blood and ”collect” the extra iron and facilitate its elimination from the body.

 

To improve symptoms diuretics may be prescribed. These are medications that increase the urine output, and thus, decrease blood volume and blood pressure. As a result, the heart will need to work less to overcome the pressure in the circulation to eject blood. Other medications include beta blockers that can slow the heart rate and increase the time when the heart is relaxed. This gives more time for the heart to be filled with blood. Angiotensin converting enzyme (ACE) inhibitors lower the blood pressure and reduce the workload of the heart. If the individual is at risk of forming blood clots, anticoagulants may be prescribed to prevent clot formation that could cause a stroke or other complications. In addition, lifestyle changes such as dietary modifications can help lower blood pressure. 

 

The choice of medication and specific therapy for RCM depends on the underlying condition, risk of complications, the ability of the patient to tolerate the therapy, and other case-specific factors.

 

The prognosis of RCM varies among affected individuals and depends on the underlying cause, the severity and the rate of progression, the presence of other medical conditions affecting the heart, etc. RCM is a progressive condition and tends to worsen over time and may ultimately lead to heart failure. Generally speaking, half of the individuals who develop heart failure survive beyond 5 years after diagnosis. Prognosis is better for adults with RCM compared to affected children.

 

Tips or Suggestions of Restrictive Cardiomyopathy has not been added yet.

Albakri A. Restrictive cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management. Pediatr Dimens 3. 2018. DOI: 10.15761/PD.1000170

 

Beutler E. Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis. 2007;39(2):140-147. doi:10.1016/j.bcmd.2007.03.009

 

Bhatti K, Bandlamudi M, Lopez-Mattei J. Endomyocardial Fibrosis. [Updated 2020 Aug 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www-ncbi-nlm-nih-gov.proxy1.lib.uwo.ca/books/NBK513293/

 

Brown KN, Pendela VS, Diaz RR. Restrictive Cardiomyopathy. [Updated 2020 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537234/

 

Muchtar E, Blauwet LA, and Gertz MA. Restrictive Cardiomyopathy. Circulation Research. 2017;121:819–837. https://doi.org/10.1161/CIRCRESAHA.117.310982

 

Rammos A, Meladinis V, Vovas G, Patsouras D. Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review. Radiol Res Pract. 2017;2017:2874902. doi:10.1155/2017/2874902

 

Zangwill S, and Hamilton R. Restrictive Cardiomyopathy. Pacing and Clinical Electrophysiology. 2009; 32: S41-S43. https://doi-org.proxy1.lib.uwo.ca/10.1111/j.1540-8159.2009.02383.x

Community Details Update Created by RareshareTeam
Last updated 20 Feb 2021, 05:15 PM

Posted by RareshareTeam
20 Feb 2021, 05:15 PM

Hi everyone,

The Restrictive Cardiomyopathy community details have been updated. We added more information about the cause, prevalence, symptoms, diagnosis, and treatment. Hopefully, you find it helpful. 

Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

I am a nurse who loved to excercise.competed in a couple of triathlons before my ability to excercise inexplicably began to diminish. I worked full time unitl last April when symptoms progressed to...

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Community Details Update

Created by RareshareTeam | Last updated 20 Feb 2021, 05:15 PM


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.